A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of using a higher dosage of ...
March 29, 2012 (Orlando, Florida) — Results of the largest study to date assessing the efficacy of radioembolization with yttrium-90 microspheres in the treatment of unresectable hepatic tumors have ...
Options for Endocrine-Refractory, Hormone Receptor–Positive Breast Cancer: Which Target and When? In this international, multicenter, open-label phase III trial, patients with CLM who progressed on ...
Analysis revealed survival for patients with hepatocellular carcinoma (HCC) is achievable using 90Y-resin microsphere radioembolization. The analysis conducted at multiple centers across Europe showed ...
May 3, 2009 (Copenhagen, Denmark) — A phase 2 study of radioembolization with yttrium-90 has shown it to be effective and safe for the treatment of advanced hepatocellular carcinoma (HCC), with or ...
Transarterial yttrium-90 radioembolization (TARE) combined with second-line chemotherapy improved progression-free survival (PFS) in patients with unresectable colorectal cancer liver metastases, ...
Radioembolization is a generally painless procedure for liver cancer that directly targets the blood supply to the tumor site. Approximately 70% to 95% of patients will experience improvements in ...
The majority of patients with advanced colorectal cancer die from hepatic metastases caused by disease progression; therefore, several novel technologies are in clinical development to potentially ...
Background. A 58-year-old white man who was being followed by his hepatologist for nonalcoholic steatohepatitis-related liver cirrhosis and portal hypertension and who had been found to have a ...
INDIANAPOLIS -- The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists at the Indiana University School ...
Please provide your email address to receive an email when new articles are posted on . There are four scenarios in which patients with HCC and extrahepatic disease (EHD) should be considered for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results